Clinical Trial Update: A Study to Evaluate the Potential Role of Mesenchymal Stem Cells in the Treatment of Idiopathic Pulmonary Fibrosis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating mesenchymal stem cells for idiopathic pulmonary fibrosis; trial completed and results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• Mesenchymal stem cell therapy (mesenchymal stem cells)

Snippet

Sponsor: The Prince Charles Hospital | Conditions: Idiopathic Pulmonary Fibrosis | Phase 1 | Status: COMPLETED | Results posted: 2015-12-29